Literature DB >> 31189406

Integrating Quality of Life and Survival Outcomes in Cardiovascular Clinical Trials.

Jacob V Spertus1, Laura A Hatfield2, David J Cohen3,4, Suzanne V Arnold3,4, Martin Ho5, Philip G Jones3, Martin Leon6, Bram Zuckerman5, John A Spertus3,4.   

Abstract

Background Survival and health status (eg, symptoms and quality of life) are key outcomes in clinical trials of heart failure treatment. However, health status can only be recorded on survivors, potentially biasing treatment effect estimates when there is differential survival across treatment groups. Joint modeling of survival and health status can address this bias. Methods and Results We analyzed patient-level data from the PARTNER 1B trial (Placement of Aortic Transcatheter Valves) of transcatheter aortic valve replacement versus standard care. Health status was quantified with the Kansas City Cardiomyopathy Questionnaire (KCCQ) at randomization, 1, 6, and 12 months. We compared hazard ratios for survival and mean differences in KCCQ scores at 12 months using several models: the original growth curve model for KCCQ scores (ignoring death), separate Bayesian models for survival and KCCQ scores, and a Bayesian joint longitudinal-survival model fit to either 12 or 30 months of survival follow-up. The benefit of transcatheter aortic valve replacement on 12-month KCCQ scores was greatest in the joint-model fit to all survival data (mean difference, 33.7 points; 95% credible intervals [CrI], 24.2-42.4), followed by the joint-model fit to 12 months of survival follow-up (32.3 points; 95% CrI, 22.5-41.5), a Bayesian model without integrating death (30.4 points; 95% CrI, 21.4-39.3), and the original growth curve model (26.0 points; 95% CI, 18.7-33.3). At 12 months, the survival benefit of transcatheter aortic valve replacement was also greater in the joint model (hazard ratio, 0.50; 95% CrI, 0.32-0.73) than in the nonjoint Bayesian model (0.54; 95% CrI, 0.37-0.75) or the original Kaplan-Meier estimate (0.55; 95% CI, 0.40-0.74). Conclusions In patients with severe symptomatic aortic stenosis and prohibitive surgical risk, the estimated benefits of transcatheter aortic valve replacement on survival and health status compared with standard care were greater in joint Bayesian models than other approaches.

Entities:  

Keywords:  health status; heart failure; quality of life; risk; transcatheter aortic valve replacement

Mesh:

Year:  2019        PMID: 31189406      PMCID: PMC6579042          DOI: 10.1161/CIRCOUTCOMES.118.005420

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  23 in total

1.  Bayesian semiparametric models for survival data with a cure fraction.

Authors:  J G Ibrahim; M H Chen; D Sinha
Journal:  Biometrics       Date:  2001-06       Impact factor: 2.571

2.  Joint modeling of longitudinal and survival data via a common frailty.

Authors:  Sarah J Ratcliffe; Wensheng Guo; Thomas R Ten Have
Journal:  Biometrics       Date:  2004-12       Impact factor: 2.571

3.  Statistical analysis of longitudinal quality of life data with missing measurements.

Authors:  A H Zwinderman
Journal:  Qual Life Res       Date:  1992-06       Impact factor: 4.147

4.  Monitoring clinical changes in patients with heart failure: a comparison of methods.

Authors:  John Spertus; Eric Peterson; Mark W Conard; Paul A Heidenreich; Harlan M Krumholz; Philip Jones; Peter A McCullough; Ileana Pina; Joseph Tooley; William S Weintraub; John S Rumsfeld
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

Review 5.  Basic concepts and methods for joint models of longitudinal and survival data.

Authors:  Joseph G Ibrahim; Haitao Chu; Liddy M Chen
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

6.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

Authors:  C P Green; C B Porter; D R Bresnahan; J A Spertus
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

7.  Prognostic value of health status in patients with heart failure after acute myocardial infarction.

Authors:  Gabriel E Soto; Philip Jones; William S Weintraub; Harlan M Krumholz; John A Spertus
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

8.  Health status identifies heart failure outpatients at risk for hospitalization or death.

Authors:  Paul A Heidenreich; John A Spertus; Philip G Jones; William S Weintraub; John S Rumsfeld; Saif S Rathore; Eric D Peterson; Frederick A Masoudi; Harlan M Krumholz; Edward P Havranek; Mark W Conard; Randall E Williams
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

9.  Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments.

Authors:  Mikhail Kosiborod; Gabriel E Soto; Philip G Jones; Harlan M Krumholz; William S Weintraub; Prakash Deedwania; John A Spertus
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

10.  Assessing response bias from missing quality of life data: the Heckman method.

Authors:  Anne E Sales; Mary E Plomondon; David J Magid; John A Spertus; John S Rumsfeld
Journal:  Health Qual Life Outcomes       Date:  2004-09-16       Impact factor: 3.186

View more
  5 in total

1.  Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.

Authors:  John A Spertus; Philip G Jones; David J Maron; Daniel B Mark; Sean M O'Brien; Jerome L Fleg; Harmony R Reynolds; Gregg W Stone; Mandeep S Sidhu; Bernard R Chaitman; Glenn M Chertow; Judith S Hochman; Sripal Bangalore
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

2.  Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.

Authors:  John A Spertus; Philip G Jones; David J Maron; Sean M O'Brien; Harmony R Reynolds; Yves Rosenberg; Gregg W Stone; Frank E Harrell; William E Boden; William S Weintraub; Khaula Baloch; Kreton Mavromatis; Ariel Diaz; Gilbert Gosselin; Jonathan D Newman; Stavroula Mavromichalis; Karen P Alexander; David J Cohen; Sripal Bangalore; Judith S Hochman; Daniel B Mark
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

3.  Exercise Training Effects on the Relationship of Physical Function and Health-Related Quality of Life Among Older Heart Failure Patients With Preserved Ejection Fraction.

Authors:  Peter H Brubaker; Teagan Avis; W Jack Rejeski; Shannon E Mihalko; Wesley J Tucker; Dalane W Kitzman
Journal:  J Cardiopulm Rehabil Prev       Date:  2020-11       Impact factor: 3.646

4.  Novel Trial Design: CHIEF-HF.

Authors:  John A Spertus; Mary C Birmingham; Javed Butler; Ildiko Lingvay; David E Lanfear; Antonio Abbate; Mikhail L Kosiborod; Christina Fawcett; Paul Burton; C V Damaraju; James L Januzzi; John Whang
Journal:  Circ Heart Fail       Date:  2021-03-16       Impact factor: 8.790

Review 5.  Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care: A Review.

Authors:  Merrill Thomas; Philip G Jones; Suzanne V Arnold; John A Spertus
Journal:  JAMA Cardiol       Date:  2021-05-01       Impact factor: 14.676

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.